pubmed:abstractText |
Zinc is involved in several physiologic processes, including cell growth and proliferation. Although in normal prostate tissue zinc levels are high, there is a marked decrease in prostate cancer. Metallothioneins control the bioavailability of zinc and one isoform, MT1G, was reported down-regulated in prostate cancer. Here, we investigated whether promoter methylation might cause MT1G silencing in prostate cancer.
|
pubmed:affiliation |
Department of Genetics, Portuguese Oncology Institute, Porto, Rua Dr. Antonio Bernardino Almeida, 4200-072 Porto, Portugal.
|